• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制备方法对尼莫地平与SBE-β-CD/HP-β-CD形成真性包合物及其溶出速率提高的影响。

Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.

作者信息

Semcheddine Farouk, Guissi Nida El Islem, Liu XueYin, Wu ZuoMin, Wang Bo

机构信息

Department of Pharmaceutics, China Pharmaceutical University, Tongjiaxiang 24#, Nanjing, 210009, China,

出版信息

AAPS PharmSciTech. 2015 Jun;16(3):704-15. doi: 10.1208/s12249-014-0257-x. Epub 2014 Dec 17.

DOI:10.1208/s12249-014-0257-x
PMID:25511809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4444620/
Abstract

The aims of this study were to enhance the solubility and dissolution rate of nimodipine (ND) by preparing the inclusion complexes of ND with sulfobutylether-b-cyclodextrin (SBE-β-CD) and 2-hydroxypropyl-b-cyclodextrin (HP-β-CD) and to study the effect of the preparation method on the in vitro dissolution profile in different media (0.1 N HCl pH 1.2, phosphate buffer pH 7.4, and distilled water). Thus, the inclusion complexes were prepared by kneading, coprecipitation, and freeze-drying methods. Phase solubility studies were conducted to characterize the complexes in the liquid state. The inclusion complexes in the solid state were investigated with differential scanning calorimetry (DSC), X-ray diffractometry (X-RD), and Fourier transform infrared spectroscopy (FT-IR). Stable complexes of ND/SBE-β-CD and ND/HP-β-CD were formed in distilled water in a 1:1 stoichiometric inclusion complex as indicated by an AL-type diagram. The apparent stability constants (Ks) were 1334.4 and 464.1 M(-1) for ND/SBE-β-CD and ND/HP-β-CD, respectively. The water-solubility of ND was significantly increased in an average of 22- and 8-fold for SBE-β-CD and HP-β-CD, respectively. DSC results showed the formation of true inclusion complexes between the drug and both SBE-β-CD and HP-β-CD prepared by the kneading method. In contrast, crystalline drug was detectable in all other products. The dissolution studies showed that all the products exhibited higher dissolution rate than those of the physical mixtures and ND alone, in all mediums. However, the kneading complexes displayed the maximum dissolution rate in comparison with drug and other complexes, confirming the influence of the preparation method on the physicochemical properties of the products.

摘要

本研究的目的是通过制备尼莫地平(ND)与磺丁基醚 -β-环糊精(SBE-β-CD)和2-羟丙基 -β-环糊精(HP-β-CD)的包合物来提高尼莫地平的溶解度和溶出速率,并研究制备方法对其在不同介质(0.1 N HCl pH 1.2、pH 7.4的磷酸盐缓冲液和蒸馏水)中体外溶出曲线的影响。因此,通过捏合、共沉淀和冷冻干燥法制备了包合物。进行相溶解度研究以表征液态下的复合物。采用差示扫描量热法(DSC)、X射线衍射法(X-RD)和傅里叶变换红外光谱法(FT-IR)对固态包合物进行了研究。如AL型图所示,在蒸馏水中以1:1化学计量比形成了稳定的ND/SBE-β-CD和ND/HP-β-CD包合物。ND/SBE-β-CD和ND/HP-β-CD的表观稳定常数(Ks)分别为1334.4和464.1 M⁻¹。对于SBE-β-CD和HP-β-CD,ND的水溶性平均分别显著提高了22倍和8倍。DSC结果表明,通过捏合法制备的药物与SBE-β-CD和HP-β-CD之间均形成了真正的包合物。相比之下,在所有其他产品中均可检测到结晶药物。溶出度研究表明,在所有介质中,所有产品的溶出速率均高于物理混合物和单独的ND。然而,与药物和其他包合物相比,捏合包合物的溶出速率最高,证实了制备方法对产品理化性质的影响。

相似文献

1
Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.制备方法对尼莫地平与SBE-β-CD/HP-β-CD形成真性包合物及其溶出速率提高的影响。
AAPS PharmSciTech. 2015 Jun;16(3):704-15. doi: 10.1208/s12249-014-0257-x. Epub 2014 Dec 17.
2
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.他达拉非与天然及化学修饰的β-环糊精的包合物。I:制备及体外评价
Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.
3
Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.依托度酸与羟丙基-β-环糊精及辅助剂的包合作用:制剂表征与分子模拟研究
Mol Pharm. 2017 Apr 3;14(4):1231-1242. doi: 10.1021/acs.molpharmaceut.6b01115. Epub 2017 Mar 1.
4
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.通过形成西洛他唑包合物提高其口服生物利用度。
AAPS PharmSciTech. 2009;10(2):660-9. doi: 10.1208/s12249-009-9249-7. Epub 2009 May 21.
5
Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.采用超临界抗溶剂(SAS)法制备辛伐他汀/羟丙基-β-环糊精包合物及其表征
Eur J Pharm Biopharm. 2007 Jun;66(3):413-21. doi: 10.1016/j.ejpb.2006.11.013. Epub 2006 Nov 29.
6
Preparation and characterization of mosapride citrate inclusion complexes with natural and synthetic cyclodextrins.制备并表征枸橼酸莫沙必利与天然和合成环糊精的包合物。
Pharm Dev Technol. 2013 Sep-Oct;18(5):1042-50. doi: 10.3109/10837450.2011.646425. Epub 2011 Dec 30.
7
Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.β-环糊精对诺氟沙星A晶型性质的影响
AAPS PharmSciTech. 2015 Jun;16(3):683-91. doi: 10.1208/s12249-014-0259-8. Epub 2014 Dec 16.
8
Manufacturing and Assessing the New Orally Disintegrating Tablets, Containing Nimodipine-hydroxypropyl-β-cyclodextrin and Nimodipine-methyl-β-cyclodextrin Inclusion Complexes.制备和评价尼莫地平-羟丙基-β-环糊精和尼莫地平-甲基-β-环糊精包合物的新型口腔崩解片。
Molecules. 2022 Mar 21;27(6):2012. doi: 10.3390/molecules27062012.
9
Preparation and Characterization of the Sulfobutylether-β-Cyclodextrin Inclusion Complex of Amiodarone Hydrochloride with Enhanced Oral Bioavailability in Fasted State.盐酸胺碘酮磺丁基醚-β-环糊精包合物的制备与表征:禁食状态下口服生物利用度提高
AAPS PharmSciTech. 2017 Jul;18(5):1526-1535. doi: 10.1208/s12249-016-0646-4. Epub 2016 Oct 18.
10
Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.依折麦布与羟丙基-β-环糊精及亲水性辅料制剂的水溶解度改善及抗高胆固醇活性
AAPS PharmSciTech. 2016 Apr;17(2):272-83. doi: 10.1208/s12249-015-0344-7. Epub 2015 Jun 16.

引用本文的文献

1
Inclusion Complex of Nimodipine with Sulfobutylether-β-cyclodextrin: Preparation, Characterization, In Vitro and In Vivo Evaluation.尼莫地平与磺丁基醚-β-环糊精的包合物:制备、表征、体外和体内评价
AAPS PharmSciTech. 2025 Jan 8;26(1):28. doi: 10.1208/s12249-024-03014-2.
2
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs.增溶方法的进展:迈向提高难溶性药物生物利用度的一步。
Life (Basel). 2023 Apr 27;13(5):1099. doi: 10.3390/life13051099.
3
Cyclodextrin Derivative Enhances the Ophthalmic Delivery of Poorly Soluble Azithromycin.环糊精衍生物增强难溶性阿奇霉素的眼部给药效果。
ACS Omega. 2022 Jun 24;7(27):23050-23060. doi: 10.1021/acsomega.1c07218. eCollection 2022 Jul 12.
4
Manufacturing and Assessing the New Orally Disintegrating Tablets, Containing Nimodipine-hydroxypropyl-β-cyclodextrin and Nimodipine-methyl-β-cyclodextrin Inclusion Complexes.制备和评价尼莫地平-羟丙基-β-环糊精和尼莫地平-甲基-β-环糊精包合物的新型口腔崩解片。
Molecules. 2022 Mar 21;27(6):2012. doi: 10.3390/molecules27062012.
5
Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study.吸入伊维菌素作为治疗 COVID-19 的重新定位直接药物的安全性:临床前耐受研究。
Int Immunopharmacol. 2021 Oct;99:108004. doi: 10.1016/j.intimp.2021.108004. Epub 2021 Jul 23.
6
Nimodipine Ophthalmic Formulations for Management of Glaucoma.用于治疗青光眼的尼莫地平眼用制剂。
Pharm Res. 2017 Apr;34(4):809-824. doi: 10.1007/s11095-017-2110-x. Epub 2017 Feb 2.
7
Characterization of pioglitazone cyclodextrin complexes: Molecular modeling to in vivo evaluation.吡格列酮环糊精复合物的表征:从分子模拟到体内评估
J Pharm Bioallied Sci. 2016 Apr-Jun;8(2):161-9. doi: 10.4103/0975-7406.171680.

本文引用的文献

1
Genistein in 1:1 inclusion complexes with ramified cyclodextrins: theoretical, physicochemical and biological evaluation.金雀异黄素与支链环糊精形成的1:1包合物:理论、物理化学及生物学评价
Int J Mol Sci. 2014 Jan 27;15(2):1962-82. doi: 10.3390/ijms15021962.
2
Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-β-cyclodextrin complex for ophthalmic delivery.基于分子建模的多西环素和羟丙基-β-环糊精包合物的眼科递药的包合机制和稳定性研究。
AAPS PharmSciTech. 2013 Mar;14(1):10-8. doi: 10.1208/s12249-012-9877-1. Epub 2012 Nov 17.
3
Cyclodextrin inclusion complex to improve physicochemical properties of herbicide bentazon: exploring better formulations.环糊精包合物改善除草剂苯达松的理化性质:探索更好的配方。
PLoS One. 2012;7(8):e41072. doi: 10.1371/journal.pone.0041072. Epub 2012 Aug 27.
4
Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.磺丁基醚-β-环糊精(SBE-β-CD)包合物的制备、表征、分子模拟及体内抗癫痫活性评价。
AAPS PharmSciTech. 2011 Dec;12(4):1163-75. doi: 10.1208/s12249-011-9685-z. Epub 2011 Sep 15.
5
Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.依非韦伦-环糊精包合物的物理化学表征
AAPS PharmSciTech. 2009;10(1):81-7. doi: 10.1208/s12249-008-9180-3. Epub 2009 Jan 16.
6
Synthesis and characterization of beta-cyclodextrin inclusion complex containing di(8-hydroxyquinoline) magnesium.含二(8-羟基喹啉)镁的β-环糊精包合物的合成与表征
Spectrochim Acta A Mol Biomol Spectrosc. 2008 Sep;70(4):878-883. doi: 10.1016/j.saa.2007.10.004.
7
Detecting and identifying the complexation of nimodipine with hydroxypropyl-beta-cyclodextrin present in tablets by Raman spectroscopy.通过拉曼光谱法检测和鉴定片剂中尼莫地平与羟丙基-β-环糊精的络合情况。
J Pharm Sci. 2008 Jul;97(7):2702-19. doi: 10.1002/jps.21204.
8
The utility of cyclodextrins for enhancing oral bioavailability.环糊精在提高口服生物利用度方面的效用。
J Control Release. 2007 Nov 6;123(2):78-99. doi: 10.1016/j.jconrel.2007.07.018. Epub 2007 Aug 16.
9
Part I: characterization of solid dispersions of nimodipine prepared by hot-melt extrusion.第一部分:热熔挤出法制备的尼莫地平固体分散体的表征
Drug Dev Ind Pharm. 2007 Jul;33(7):791-802. doi: 10.1080/03639040601050213.
10
Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.槲皮素-β-环糊精复合物的物理化学与结构表征
J Pharm Sci. 2005 May;94(5):1079-89. doi: 10.1002/jps.20325.